Elevated cerebrospinal fluid concentrations of MMP-3 and MMP-9 have been correlated with both the duration and severity of AD, suggesting their involvement in BBB disruption, amyloid precursor protein processing, and neuroinflammatory amplification. The gene discussed is APP; the disease is Alzheimer disease.